Literature DB >> 6201111

Anti-immunoglobulins and their idiotypes: are they part of the immune network?

H G Kunkel, D N Posnett, B Pernis.   

Abstract

The anti-gamma globulins represent a very heterogeneous group of proteins with widely different specificities that might be considered a portion of the immune network. The hypothesis is presented that at least some of these proteins have other specificities, with the anti-gamma globulin reactivity being a secondary property. Anti-idiotypic antibodies are possible candidates. This is based on the low binding affinity for gamma globulin of many of these proteins and the results of CRI and sequence studies. All the proteins of the major CRI group have VKIIIb light chains, and these have a dominant but not total influence on this CRI. This has been evident from studies with rabbit antibodies and recently also with monoclonal hybridoma antibodies. Sequence studies have also demonstrated the similarity in light chains that, however, are not greater than with other VKIIIb chains; the heavy chains show little similarity except possibly in the J segment. The possibility is discussed that antibodies with secondary anti-gamma globulin binding properties might have selective advantages.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6201111     DOI: 10.1111/j.1749-6632.1983.tb18082.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  6 in total

Review 1.  What can we learn about rheumatoid arthritis from animal models?

Authors:  L Klareskog
Journal:  Springer Semin Immunopathol       Date:  1989

2.  Common IgA and IgM rheumatoid factor idiotypes in autoimmune diseases.

Authors:  A E Gharavi; B M Patel; G R Hughes; K B Elkon
Journal:  Ann Rheum Dis       Date:  1985-03       Impact factor: 19.103

3.  IgM, IgG and IgA rheumatoid factors and circulating immune complexes in patients with AIDS and AIDS-related complex with serological abnormalities.

Authors:  S Procaccia; A Lazzarin; A Colucci; A Gasparini; P Forcellini; D Lanzanova; C U Foppa; R Novati; C Zanussi
Journal:  Clin Exp Immunol       Date:  1987-02       Impact factor: 4.330

4.  Class-specific rheumatoid factors, DR antigens, and amyloidosis in patients with rheumatoid arthritis.

Authors:  C P Maury; A M Teppo; F Wafin; O Wegelius; C Friman; S Koskimies
Journal:  Ann Rheum Dis       Date:  1988-07       Impact factor: 19.103

5.  Immunogenic and antigenic epitopes of immunoglobulins. XVII--Monoclonal antibodies reactive with common and restricted idiotopes to the heavy chain of human rheumatoid factors.

Authors:  R A Mageed; M Dearlove; D M Goodall; R Jefferis
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

6.  Characterization of human rheumatoid factors with seven antiidiotypes induced by synthetic hypervariable region peptides.

Authors:  P P Chen; F Gõni; R A Houghten; S Fong; R Goldfien; J H Vaughan; B Frangione; D A Carson
Journal:  J Exp Med       Date:  1985-08-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.